Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is 4.91%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
4.91%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Minerva Neurosciences, Inc.
Market Cap
$157.00M
EBITDA Margin
4.91%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.86M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.42M
EBITDA Margin
-3676.90%
TTM Avg
-2033.97%
3Y Avg
-1569.70%
5Y Avg
-1569.70%
Market Cap
$154.46M
EBITDA Margin
-48812.58%
TTM Avg
-48812.58%
3Y Avg
-48812.58%
5Y Avg
-48812.58%
Market Cap
$152.26M
EBITDA Margin
-47.00%
TTM Avg
-68.63%
3Y Avg
-61.93%
5Y Avg
-48.63%
Market Cap
$150.59M
EBITDA Margin
-550.97%
TTM Avg
-275.49%
3Y Avg
-275.49%
5Y Avg
-275.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $157.00M | 4.91% | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $157.49M | -2.74% | -4.58% | -13.60% | -7.28% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $155.42M | -3676.90% | -2033.97% | -1569.70% | -1569.70% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $154.46M | -48812.58% | -48812.58% | -48812.58% | -48812.58% |
| Codexis, Inc. (CDXS)vs › | $152.26M | -47.00% | -68.63% | -61.93% | -48.63% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | N/A | N/A | N/A | N/A |
| PepGen Inc. (PEPG)vs › | $163.59M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.59M | -550.97% | -275.49% | -275.49% | -275.49% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -416.41% | -228.13% | -163.44% | -116.60% |
Gross Margin
0.0%
EBITDA Margin
4.9%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2020-06-30 | 71.77% |
